Work

A Phase II Clinical Trial Of Lenalidomide and Prednisone In Low and Intermediate-1 IPSS Risk, Non-Del (5q) MDS Patients

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.1506.1506

Authors: Rami S Komrokji, Najla H Al Ali, Eric Padron, Ji-Hyun Lee, Nancy Hillgruber, Sara Tinsley, Jeffrey E Lancet, Alan List

Institution: Moffitt Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2280923005

FWCI: 0.475

Cites:

Cited by: 3

Related to: 10